{"id":"W2149908785","doi":"10.1056/nejmoa052306","title":"Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer","year":2005,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":5098,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; McGill University","funders":"","keywords":"Trastuzumab; Medicine; Breast cancer; Oncology; Chemotherapy; Adjuvant; Monoclonal antibody; Internal medicine; Adjuvant chemotherapy; Cancer; Stage (stratigraphy); Antibody; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001307874,0.0001884257,0.0005863534,0.0001775647,0.0001228341,0.0003011347,0.0002575014,0.0003418625,0.0008242241],"category_scores_gemma":[0.001487557,0.00007307741,0.0003483745,0.0003000795,0.0002208555,0.0002027053,0.0001897777,0.0006771703,0.00009323444],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003988289,"about_ca_system_score_gemma":0.0004413665,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000313991,"about_ca_topic_score_gemma":0.0006878774,"domain_scores_codex":[0.999585,0.0002423513,0.00002575208,0.00003484609,0.00005046497,0.00006155474],"domain_scores_gemma":[0.9993491,0.0002713102,0.0001822119,0.00004067579,0.00003107558,0.0001255307],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4696186,0.009856511,0.04331169,0.001812999,0.001174904,0.0008342626,0.0002096251,0.005179894,0.02381461,0.0007855524,0.0029691,0.4404322],"study_design_scores_gemma":[0.3173281,0.4750189,0.1349772,0.0006439401,0.002776466,0.002126566,0.0001115352,0.005072367,0.02327482,0.00173319,0.03689735,0.00003958838],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9837577,0.01402441,0.0002840728,0.0003107307,0.0001388052,0.0001727349,0.00006956055,0.00001028476,0.001231713],"genre_scores_gemma":[0.9949072,0.003584093,0.0002956689,0.0002170591,0.0001359794,0.0001868884,0.0001896194,0.000002787309,0.0004806323],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001307874,"threshold_uncertainty_score":0.006916761,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01611926741677746,"score_gpt":0.3460186708027299,"score_spread":0.3298994033859524,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}